Thyroid-like ophthalmopathy in a euthyroid patient receiving Ipilimumab

Orbit. 2014 Dec;33(6):424-7. doi: 10.3109/01676830.2014.949792. Epub 2014 Sep 10.

Abstract

A 68-year-old lady with metastatic malignant melanoma was treated with Ipilimumab. She presented to Eye Casualty unable to move her eyes. Physical examination confirmed ophthalmoplegia and identified proptosis bilaterally. Radiological imaging showed bilateral enlargement of all the extra-ocular muscles suggestive of thyroid eye disease. Laboratory investigations found this patient to be euthyroid. A diagnosis of thyroid-like orbitopathy secondary to Ipilimumab therapy was made. Thyroid function tests should be performed for all patients prior to their commencement of Ipilimumab. Thyroid-like eye disease may develop in patients treated with Ipilimumab even if they remain euthyroid.

Keywords: Ipilimumab; myositis; thyroid eye disease; thyroid orbitopathy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Euthyroid Sick Syndromes / blood
  • Euthyroid Sick Syndromes / complications*
  • Exophthalmos / chemically induced
  • Exophthalmos / diagnosis
  • Female
  • Glucocorticoids / therapeutic use
  • Graves Ophthalmopathy / chemically induced*
  • Graves Ophthalmopathy / diagnosis
  • Graves Ophthalmopathy / drug therapy
  • Humans
  • Ipilimumab
  • Melanoma / drug therapy
  • Melanoma / secondary
  • Methylprednisolone / therapeutic use
  • Ophthalmoplegia / chemically induced
  • Ophthalmoplegia / diagnosis
  • Thyroid Function Tests
  • Thyrotropin / blood
  • Thyroxine / blood

Substances

  • Antibodies, Monoclonal
  • Glucocorticoids
  • Ipilimumab
  • Thyrotropin
  • Thyroxine
  • Methylprednisolone